Newsroom

Sorted by: Latest

-

H2SITE obtient un financement de 3,4 millions EUR (39,1 millions NOK) auprès d’Enova pour développer à grande échelle la technologie de conversion de l’ammoniac en énergie à bord des navires à des fins commerciales

BILBAO, Espagne et BERGEN, Norvège--(BUSINESS WIRE)--H2SITE a obtenu un financement de 3,4 millions EUR (39,1 millions NOK) auprès d’Enova pour HydraNord Power, un projet visant à développer et à valider un système embarqué de conversion de l’ammoniac en énergie à l’échelle commerciale pour le secteur maritime. Enova est l’un des principaux instruments du gouvernement norvégien pour accélérer la transition climatique et énergétique du pays. Sa mission principale consiste à gérer le Fonds pour l...
-

H2SITE obtiene una financiación de 3,4 millones de euros (39,1 millones de coronas noruegas) de Enova para ampliar la tecnología de generación de energía a partir de amoníaco a bordo destinada a usos marítimos comerciales

BILBAO, España, y BERGEN, Noruega--(BUSINESS WIRE)--H2SITE ha obtenido una financiación de 3,4 millones de euros (39,1 millones de coronas noruegas) de Enova para HydraNord Power, un proyecto que desarrollará y validará un sistema a bordo de conversión de amoníaco en energía a escala comercial para el sector marítimo. Enova es uno de los principales instrumentos del Gobierno noruego para acelerar la transición climática y energética del país. Su principal responsabilidad es gestionar el Fondo p...
-

ZAP-X to Debut in Thailand, Bringing Advanced Brain Radiosurgery to Southeast Asia

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Vibharam Amatanakorn Specialized Cancer Hospital in Chonburi Province, Thailand, will install the first ZAP-X® Gyroscopic Radiosurgery® platform in Thailand and Southeast Asia.Located approximately 90 minutes southeast of Bangkok, Chonburi is a strategic economic hub within Thailand’s Eastern Economic Corridor (EEC) and a major coastal destination on the Gu...
-

Cyera Announces $400 Million Investment from Goldman Sachs to Build the Trust Layer for the Agentic Enterprise

NEW YORK--(BUSINESS WIRE)--AI agents are becoming the new enterprise workforce, promising enormous gains in productivity, speed, and innovation. Unlike traditional software, they reason, use identities, call tools, access sensitive data, and take action autonomously at machine speed. The more access agents have, the more valuable they become and the greater the risk when that access is compromised or misaligned with business intent. That combination makes agents one of the fastest-growing secur...
-

Xapien Partners With ServiceNow to Bring AI-Native Due Diligence Into Enterprise Workflows

BOSTON--(BUSINESS WIRE)--Xapien - Less than two weeks after announcing a $56 million investment round from Spectrum Equity and YFM Equity Partners, and its U.S. expansion plans, Xapien is bringing its dynamic due diligence natively into ServiceNow, the AI control tower for business reinvention. The integration embeds automated, fully-sourced research directly into the ServiceNow workflows where onboarding and third-party risk are managed. Organizations face growing pressure to assess third-part...
-

Everforth ECS Secures Position on $58M CPSC Data Solutions BPA

FAIRFAX, Va.--(BUSINESS WIRE)--Everforth ECS Secures Position on $58M CPSC Data Solutions BPA...
-

Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes

SAN FRANCISCO & NEW YORK & MONTREAL--(BUSINESS WIRE)--Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today announced a partnership with Breakthrough T1D, the leading global Type 1 Diabetes (T1D) research and advocacy organization, and an award through its Industry Discovery and Development Partnership (IDDP) program to support the advancement of Encellin’s ENCRT-103-hPI clinical program in T1D. The new trial (NCT07680673) will br...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 21.09.2026 FEM IE00B8X9NX34  300,002.00 USD  15,444,596.08   51.482  ...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 21.09.2026 FEUZ IE00B8X9NY41 1,681,199.00 EUR 109,284,642.44   65.004  ...